GJMEDI INC.

Pipeline

Acquired 25 intellectual property achievements in addition to patent registrations.

Major Pipeline

< Scroll horizontally to view the content.>
Pipeline
2025 2027 2029
Indication Discovery Preclinical Phase1 Phase2 Phase3
Pancreatic cancer therapeutics
Lung cancer therapeutics
Breast cancer therapeutics
Liver cancer therapeutics
Colorectal cancer therapeutics
Skin cancer therapeutics
Dementia therapeutics
Viral therapeutics